AzureBio was set up by Dr Arcadio Garcia de Castro on the basis of prior experience in drug stabilisation and delivery and biotechnological business development. This experience includes senior scientific Business Development positions at OncoStem Pharma (Spain) and PharmaMar-Zeltia (Spain). Prior to this Dr G. de Castro was R&D director and founder of Cambridge Biostability Ltd. (UK), and researcher at the Univ. of Cambridge (UK) and Quadrant Healthcare (UK). Dr G. de Castro is PhD in biotechnology from the University of Surrey (UK).

AzureBio has four recent patent applications in the field of drug delivery and bone regeneration.